JP2008512117A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512117A5
JP2008512117A5 JP2007531167A JP2007531167A JP2008512117A5 JP 2008512117 A5 JP2008512117 A5 JP 2008512117A5 JP 2007531167 A JP2007531167 A JP 2007531167A JP 2007531167 A JP2007531167 A JP 2007531167A JP 2008512117 A5 JP2008512117 A5 JP 2008512117A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
domain
protein
fusion protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007531167A
Other languages
English (en)
Japanese (ja)
Other versions
JP4764881B2 (ja
JP2008512117A (ja
Filing date
Publication date
Priority claimed from US10/939,262 external-priority patent/US7807174B2/en
Application filed filed Critical
Publication of JP2008512117A publication Critical patent/JP2008512117A/ja
Publication of JP2008512117A5 publication Critical patent/JP2008512117A5/ja
Application granted granted Critical
Publication of JP4764881B2 publication Critical patent/JP4764881B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007531167A 2004-09-10 2005-07-21 新規の治療タンパク質ベースの分子クラス Expired - Lifetime JP4764881B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/939,262 US7807174B2 (en) 2002-11-22 2004-09-10 Class of therapeutic protein based molecules
US10/939,262 2004-09-10
PCT/US2005/025831 WO2006031291A2 (en) 2004-09-10 2005-07-21 A novel class of therapeutic protein based molecules

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010153231A Division JP5307082B2 (ja) 2004-09-10 2010-07-05 新規の治療タンパク質ベースの分子クラス

Publications (3)

Publication Number Publication Date
JP2008512117A JP2008512117A (ja) 2008-04-24
JP2008512117A5 true JP2008512117A5 (enExample) 2009-12-17
JP4764881B2 JP4764881B2 (ja) 2011-09-07

Family

ID=36060467

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007531167A Expired - Lifetime JP4764881B2 (ja) 2004-09-10 2005-07-21 新規の治療タンパク質ベースの分子クラス
JP2010153231A Expired - Fee Related JP5307082B2 (ja) 2004-09-10 2010-07-05 新規の治療タンパク質ベースの分子クラス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010153231A Expired - Fee Related JP5307082B2 (ja) 2004-09-10 2010-07-05 新規の治療タンパク質ベースの分子クラス

Country Status (16)

Country Link
US (2) US7807174B2 (enExample)
EP (4) EP1786902B1 (enExample)
JP (2) JP4764881B2 (enExample)
KR (1) KR20070064619A (enExample)
CN (2) CN104017787B (enExample)
AU (1) AU2005285461B2 (enExample)
BR (1) BRPI0515646B8 (enExample)
CA (2) CA2578050C (enExample)
DK (3) DK3018204T3 (enExample)
ES (3) ES2626845T3 (enExample)
IL (3) IL181779A (enExample)
PT (3) PT3241898T (enExample)
RU (1) RU2468080C2 (enExample)
TR (1) TR201905393T4 (enExample)
WO (1) WO2006031291A2 (enExample)
ZA (1) ZA200702915B (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100210528A1 (en) * 1999-03-05 2010-08-19 Leland Shapiro Compositions, methods and uses for inhibition and/or treatment of influenza infection
US8512710B2 (en) * 2002-11-22 2013-08-20 Ansun Biopharma, Inc. Class of therapeutic protein based molecules
US8084036B2 (en) * 2002-11-22 2011-12-27 Nexbio, Inc. Broad spectrum anti-viral therapeutics and prophylaxis
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
CN101002512B (zh) * 2004-11-10 2013-12-04 日立化成株式会社 附有粘着辅助剂的金属箔及使用其的印刷配线板
CA2627323A1 (en) * 2005-10-25 2007-05-03 Mnd Diagnostic Ltd. Compositions for- detecting of influenza viruses and kits and methods using same
AU2015215955B2 (en) * 2006-01-24 2016-12-01 Ansun Biopharma, Inc. Technology for preparation of macromolecular microspheres
US20070190163A1 (en) 2006-01-24 2007-08-16 Malaknov Michael P Technology for preparation of macromolecular microspheres
AU2013237761B8 (en) * 2006-01-24 2015-06-04 Ansun Biopharma, Inc. Technology for preparation of macromolecular microspheres
US8273381B1 (en) * 2006-04-14 2012-09-25 Auburn University Compositions for and methods of controlling olfactory responses to odorants
US20100143972A1 (en) * 2006-12-14 2010-06-10 Horswill Alexander R Method of Making Cyclic Polypeptides with Inteins
EP2113027B1 (en) * 2007-02-20 2014-06-18 DSM IP Assets B.V. Novel sialidase
BRPI0815057B8 (pt) 2007-08-03 2021-05-25 Romark Laboratories Lc composto, composição farmacêutica, e, uso de um composto
EA021587B1 (ru) 2009-05-12 2015-07-30 РОМАРК ЛЭБОРЕТЕРИЗ Эл. Си. Соединения галогеналкилгетероарилбензамида
EA030679B1 (ru) * 2009-06-26 2018-09-28 РОМАРК ЛЭБОРЕТЕРИЗ Эл.Си. Соединения и способы лечения гриппа
EP2459714A1 (en) * 2009-07-31 2012-06-06 Danisco US Inc. Proteases with modified pre-pro regions
CN102711807A (zh) * 2009-11-06 2012-10-03 耐百生物制药有限公司 用于在呼吸道中进行治疗和预防的方法、化合物和组合物
JP2015508780A (ja) 2012-02-17 2015-03-23 アンサン バイオファーマ，インコーポレイテッド 免疫不全患者のインフルエンザ及びパラインフルエンザウイルスを処置するための方法、化合物、及び組成物
EP2877204A2 (en) * 2012-06-28 2015-06-03 Ansun Biopharma, Inc. Microparticle formulations for delivery to the upper and central respiratory tract and methods of manufacture
EP2866792A4 (en) 2012-06-28 2016-08-17 Ansun Biopharma Inc MICROPARTICLE FORMULATIONS FOR DELIVERY TO LOWER AND CENTRAL RESPIRATORY PATHS AND METHOD OF PREPARING THEM
CA2896057C (en) 2012-12-24 2023-03-14 Maxine Bauzon Short-acting factor vii polypeptides
CN110295114A (zh) * 2013-03-15 2019-10-01 安迅生物制药公司 蛋白纯化的新颖方法
WO2014197485A1 (en) * 2013-06-03 2014-12-11 Ansun Biopharma, Inc. Anti-viral therapeutic for infection of the eye
WO2014201034A2 (en) * 2013-06-10 2014-12-18 Ansun Biopharma, Inc. Treatment for polyomavirus infection
US20160120961A1 (en) * 2013-06-10 2016-05-05 Ansun Biopharma, Inc. Treatment of merkel cell polyomavirus infection
WO2015184356A1 (en) 2014-05-30 2015-12-03 Ansun Biopharma, Inc. Treatment of middle east respiratory syndrome coronavirus
WO2016044656A1 (en) 2014-09-17 2016-03-24 Ansun Biopharma, Inc. Treatment of infection by human enterovirus d68
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
WO2016115616A1 (en) * 2015-01-21 2016-07-28 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Inhibition of cellular proteases as treatment for influenza
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
SG10202100652VA (en) * 2015-07-21 2021-03-30 Univ Jefferson Gene therapies for neurodegenerative disorders targeting ganglioside biosynthetic pathways
EP3458085B1 (en) 2016-05-20 2022-12-07 Octapharma AG Glycosylated vwf fusion proteins with improved pharmacokinetics
US11459398B2 (en) 2016-07-01 2022-10-04 The Board Of Trustees Of The Leland Stanford Junior University Conjugates for targeted cell surface editing
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
ES2986557T3 (es) * 2017-05-26 2024-11-11 Genovis Ab Enzimas para el análisis de glucanos
JP2020533404A (ja) 2017-09-05 2020-11-19 グラディエーター バイオサイエンシーズ インコーポレイテッド 細胞内送達法
MX2020007024A (es) 2018-01-03 2020-10-28 Palleon Pharmaceuticals Inc Sialidasas humanas recombinantes, proteinas de fusion de sialidasa y metodos para usar las mismas.
GB201800274D0 (en) * 2018-01-08 2018-02-21 Enzymatica Ab Novel treatments
GB201803197D0 (en) 2018-02-27 2018-04-11 Pneumagen Ltd Viral treatment
CN112739374A (zh) * 2018-07-20 2021-04-30 安迅生物制药公司 唾液酸酶向癌细胞、免疫细胞和肿瘤微环境的递送
CN109991649B (zh) * 2019-03-26 2021-04-06 华中科技大学 一种制备无机闪烁体膜的方法
JP7343890B2 (ja) * 2019-04-26 2023-09-13 国立大学法人東海国立大学機構 シアリダーゼ活性を有する酵素剤及びその利用
CN110038122A (zh) * 2019-05-23 2019-07-23 武汉真福医药股份有限公司 枯草杆菌纤溶酶在治疗支气管炎药物中的应用
US12245754B2 (en) 2019-07-03 2025-03-11 Aillis Inc. Pharmaceutical composition for treating influenza virus infections
CN111450236B (zh) * 2020-02-25 2023-04-07 西北大学 一种用于阻断冠状病毒感染的制剂
WO2021217053A1 (en) * 2020-04-24 2021-10-28 Rezolute, Inc. Plasma kallikrein inhibitors for the treatment of ards and related conditions
US20230218794A1 (en) * 2020-06-10 2023-07-13 The Penn State Research Foundation Process and system to lessen human coronavirus transmission and spread
WO2022147481A1 (en) 2020-12-30 2022-07-07 Ansun Biopharma Inc. Combination therapy of an oncolytic virus delivering a foreign antigen and an engineered immune cell expressing a chimeric receptor targeting the foreign antigen
WO2022261290A1 (en) * 2021-06-09 2022-12-15 Microbial Machines, Inc. Engineered microorganisms for detection of diseased cells

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439089A (en) 1968-03-27 1969-04-15 Merck & Co Inc Medicated hard candy
US5643758A (en) 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
DE286239T1 (de) * 1987-03-10 1994-02-24 New England Biolabs Inc Herstellung und Reinigung eines Proteins, das mit einem Bindungsprotein fusioniert ist.
RU2054180C1 (ru) 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
US5376633A (en) 1992-09-30 1994-12-27 Lezdey; John Method for deactivating viruses in blood component containers
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
DE69527924T2 (de) * 1994-06-14 2003-01-09 Genencor International, Inc. Hitzebeständige xylanasen
SI9620042A (sl) * 1995-02-27 1998-12-31 Gilead Sciences, Inc. Novi selektivni inhibitorji virusnih ali bakterijskih neuraminidaz
GB9513683D0 (en) * 1995-07-05 1995-09-06 Ciba Geigy Ag Products
AU5546898A (en) 1997-01-14 1998-08-07 Hopital Sainte-Justine Human lysosomal sialidase and therapeutic uses thereof
US6251392B1 (en) 1997-10-20 2001-06-26 Epicyte Pharmaceuticals, Inc. Epithelial cell targeting agent
US6737511B1 (en) 1999-08-16 2004-05-18 The United States Of America As Represented By The Department Of Health And Human Services Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
US20020025320A1 (en) 1999-08-20 2002-02-28 Prosper Boyaka Sialidases as mucosal adjuvants
CN1405562A (zh) * 2002-10-24 2003-03-26 肖洪武 一种唾液酸酶测定试剂
US7807174B2 (en) 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
US8084036B2 (en) 2002-11-22 2011-12-27 Nexbio, Inc. Broad spectrum anti-viral therapeutics and prophylaxis
DE10258400A1 (de) * 2002-12-13 2004-06-24 N.V. Nutricia Trans-Sialidasen aus Trypanosoma congolense
US20070190163A1 (en) 2006-01-24 2007-08-16 Malaknov Michael P Technology for preparation of macromolecular microspheres

Similar Documents

Publication Publication Date Title
JP2008512117A5 (enExample)
RU2007112502A (ru) Новый класс терапевтических белковых молекул
JP2006508193A5 (enExample)
AU2008259768B2 (en) Compositions for delivering medicaments into the lungs, uses thereof
CN116033926A (zh) 针对ace2靶向病毒可用的结合蛋白
AU2015202864A1 (en) Fibronectin type III domain based scaffold compositions, methods and uses
JP2005512522A (ja) Ｉｌ−１３ムテインタンパク質、抗体、組成物、方法および使用
JP2014506450A5 (enExample)
JP2017529326A5 (enExample)
CN113264990A (zh) 抑制新型冠状病毒（sars-cov-2）的多肽和其应用
WO2024239980A1 (zh) 重组表达蛋白在预防/或治疗呼吸道疾病中的应用
AU2010306840A1 (en) Recombinant human CC10 protein for treatment of influenza
JP7009625B2 (ja) Ｈ３ｎ２亜型インフルエンザウイルスのヘマグルチニンタンパク質の突然変異体及びその使用
JP2025170319A (ja) Ｓａｒｓ－ｃｏｖ－２阻害剤
CN117050166B (zh) 中和呼吸道合胞病毒的c-型单域抗体及应用
TW202317600A (zh) 預防多種病毒感染的多價疫苗
WO2018231838A1 (en) Hydrochloride salts of c5a receptor agonist peptides
HUE029250T2 (en) For use in the treatment of interferon-beta, influenza-induced lower respiratory diseases
WO2016200916A1 (en) Treatment of human metapneumovirus
JPH05271291A (ja) 機能性ポリペプチド
JP2024041848A (ja) 新規な抗炎症性ペプチド及びその用途
CN105542003B (zh) 一种针对rsv粘附g蛋白表面抗原的全人源单克隆抗体
CN117186239A (zh) 融合蛋白及其应用
CN107365784A (zh) 一种用于递送至中枢神经系统的融合蛋白及合成方法
CN114853911A (zh) 三叶因子2/干扰素α2融合蛋白及其防治病毒感染性疾病的应用